Baptist Health Breaks Ground on New Home of Kenneth C Griffin Neuroscience Institute

• by

• October 12, 2026

FDA Approves First Gene Therapy for Sanfilippo Syndrome Type A

Fayuvi is authorized for pediatric patients with preserved neurodevelopmental function following a study comparing treated children with a natural history cohort

• September 30, 2026

• 3 min

Medical Oddities: Alive, but convinced otherwise

A deadly conviction, healing vanilla, stormy lungs, and a COVID tea party await.

• by Teraya Smith

• October 15, 2026

• 5 min

Factors associated with 90-day mortality in adults with cryptococcal meningoencephalitis across HIV, solid organ transplant, and non-HIV, non-transplant populations

• by Bayard A. Taylor, Ameera Jamshad, Andrés F. Henao-Martínez, Charlie Garcia, David B. Cluck, Daniel B. Chastain

• October 5, 2026